Eltropag 50mg Tablet

1. Product Introduction

Eltropag 50mg Tablet contains Eltrombopag as its active ingredient. It belongs to a class of medications known as thrombopoietin receptor agonists, which help increase the production of platelets in the blood. This medicine is primarily used to treat low platelet counts (thrombocytopenia) in patients with chronic immune thrombocytopenic purpura (ITP), chronic hepatitis C infection, and aplastic anemia. Maintaining adequate platelet levels is critical for preventing excessive bleeding and bruising.

Manufactured under stringent pharmaceutical guidelines, Eltropag 50mg Tablet ensures high quality and efficacy. It is usually prescribed when standard treatments such as corticosteroids, immunoglobulins, or splenectomy (spleen removal surgery) have not been successful. Eltropag 50mg is available in a tablet form, making it convenient for oral consumption. The dosage and duration are carefully determined by a healthcare professional based on the patient’s medical condition and response to treatment.

2. Uses of Eltropag 50mg Tablet

Eltropag 50mg Tablet is indicated for various platelet-related disorders. Major uses include:

• Chronic Immune Thrombocytopenic Purpura (ITP): Treatment of adults and children (above 1 year) with low platelet counts who have not responded adequately to other therapies.

• Chronic Hepatitis C-associated Thrombocytopenia: Used to allow the initiation and maintenance of interferon-based therapy for hepatitis C by improving platelet counts.

• Severe Aplastic Anemia (SAA): For patients with bone marrow failure where standard treatments have failed or are unsuitable.

• Chemotherapy-Induced Thrombocytopenia (Off-label use): Sometimes prescribed to manage low platelet counts after cancer treatments (under medical supervision).

Remember, Eltropag is not a cure for these conditions but helps manage platelet levels to reduce the risk of bleeding and improve overall quality of life.

3. Benefits of Eltropag 50mg Tablet

Using Eltropag 50mg Tablet under proper medical guidance can offer several important benefits:

• Increased Platelet Production: By stimulating the bone marrow, it helps produce more platelets, essential for proper blood clotting.

• Reduced Risk of Bleeding: Maintains platelet counts within a safe range, thus minimizing risks of spontaneous bleeding or easy bruising.

• Improved Treatment Outcomes: In chronic hepatitis C patients, it enables the continuation of antiviral therapy without interruption due to low platelet counts.

• Alternative for Non-responders: Offers a valuable treatment option for patients who do not benefit from corticosteroids, immunoglobulins, or splenectomy.

• Convenient Oral Administration: Being an oral tablet, it offers convenience and ease of use compared to injectable therapies.

By maintaining a healthy platelet count, Eltropag 50mg helps patients lead a more active and normal life, reducing hospitalizations and improving overall well-being.

4. Side Effects

While Eltropag 50mg Tablet is generally well tolerated, some patients may experience side effects. It is important to monitor any unusual symptoms and inform your doctor promptly. Common and serious side effects include:

Common Side Effects:

• Nausea

• Diarrhea

• Headache

• Fatigue

• Muscle aches

• Cough

• Upper respiratory tract infections

Serious Side Effects (Require Immediate Medical Attention):

• Liver problems (indicated by yellowing of skin or eyes, dark urine)

• Blood clots (symptoms like chest pain, shortness of breath, leg swelling)

• Cataracts (changes in vision or blurred vision)

• Bone marrow problems (unusual bruising or bleeding, persistent fatigue)

Precautions:

• Regular liver function tests are recommended during treatment.

• Dose adjustments may be necessary based on platelet counts and liver function.

• This medicine should not be used during pregnancy unless clearly needed.

• Avoid taking antacids, dairy products, or supplements containing calcium or iron close to the time you take this medicine as they can affect absorption.

Always follow your doctor’s instructions carefully and report any side effects immediately.

5. Frequently Asked Questions (FAQs)

Q1. How does Eltropag 50mg Tablet work?
A1: Eltropag 50mg works by stimulating the thrombopoietin receptor in the bone marrow, promoting the production of new platelets and helping maintain adequate platelet levels.

Q2. Can I stop taking Eltropag once my platelet count improves?
A2: No, do not stop taking Eltropag without consulting your doctor. Abrupt discontinuation can cause platelet counts to drop, increasing the risk of bleeding.

Q3. How should I take Eltropag 50mg Tablet?
A3: Take Eltropag exactly as prescribed by your doctor, usually once daily. It should be taken on an empty stomach or with food, depending on your doctor’s advice. Avoid consuming it with dairy products or mineral supplements close to your dosing time.

Q4. Is Eltropag safe during pregnancy or breastfeeding?
A4: Eltropag should be used during pregnancy only if clearly necessary. Breastfeeding is not recommended during treatment. Always discuss with your doctor before starting or continuing the medication if you are pregnant or nursing.

Q5. What should I do if I miss a dose?
A5: If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed one and resume your regular schedule. Do not double the dose to catch up.